Ligand validation:5P94

NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5P94_NHE_A_304	39%	18%	0.13	0.834	1.65	2.06	1	2	5	0	100%	1
5LQA_NHE_A_301	97%	12%	0.064	0.982	1.48	2.78	1	5	0	0	100%	0.5
5K0F_NHE_B_301	93%	34%	0.085	0.982	0.93	1.74	-	2	0	0	100%	1
5LR6_NHE_C_501	91%	16%	0.102	0.988	2.52	1.4	2	3	0	0	100%	1
5K0N_NHE_D_303	89%	24%	0.094	0.972	1.13	2.13	2	5	1	0	100%	1
5K0G_NHE_B_301	87%	31%	0.102	0.976	0.91	1.96	-	4	1	0	100%	1
5TSP_NHE_A_1001	99%	51%	0.053	0.99	0.93	0.98	-	1	0	0	100%	1
3WXP_NHE_A_404	99%	11%	0.052	0.986	1.81	2.52	4	7	0	0	100%	0.94
3WH6_NHE_A_505	99%	15%	0.056	0.984	1.25	2.71	2	5	0	0	100%	1
3O1W_NHE_B_488	98%	19%	0.063	0.985	1.36	2.21	1	4	0	0	100%	1
3WH7_NHE_A_502	98%	22%	0.067	0.989	1.48	1.95	3	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.